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Key Points
Question
Can computer automation coupled with decision support increase timely screening for autism spectrum
disorders in primary care practice?
Findings
This cluster randomized clinical trial found that computer-based screening and decision support embedded
into the routine workflow in primary care increased rates of screening from 0% to 100%, but physicians
responded to approximately half of positive screening results.
Meaning
Automating the screening process can ensure that screening takes place, but follow-through of the results is
vulnerable to human error.
Abstract
Effect of a Computer-Based Decision Support Intervention on Autism Sp... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991212/?report=printable
2 of 17 3/25/2020, 8:12 AM
Importance
Universal early screening for autism spectrum disorder (ASD) is recommended but not routinely
performed.
Objective
To determine whether computer-automated screening and clinical decision support can improve ASD
screening rates in pediatric primary care practices.
Design, Setting, and Participants
This cluster randomized clinical trial, conducted between November 16, 2010, and November 21, 2012,
compared ASD screening rates among a random sample of 274 children aged 18 to 24 months in urban
pediatric clinics of an inner-city county hospital system with or without an ASD screening module built
into an existing decision support software system. Statistical analyses were conducted from February 6,
2017, to June 1, 2018.
Interventions
Four clinics were matched in pairs based on patient volume and race/ethnicity, then randomized within
pairs. Decision support with the Child Health Improvement Through Computer Automation system
(CHICA) was integrated with workflow and with the electronic health record in intervention clinics.
Main Outcomes and Measures
The main outcome was screening rates among children aged 18 to 24 months. Because the intervention was
discontinued among children aged 18 months at the request of the participating clinics, only results for
those aged 24 months were collected and analyzed. Rates of positive screening results, clinicians’ response
rates to screening results in the computer system, and new cases of ASD identified were also measured.
Main results were controlled for race/ethnicity and intracluster correlation.
Results
Two clinics were randomized to receive the intervention, and 2 served as controls. Records from 274
children (101 girls, 162 boys, and 11 missing information on sex; age range, 23-30 months) were reviewed
(138 in the intervention clinics and 136 in the control clinics). Of 263 children, 242 (92.0%) were enrolled
in Medicaid, 138 (52.5%) were African American, and 96 (36.5%) were Hispanic. Screening rates in the
intervention clinics increased from 0% (95% CI, 0%-5.5%) at baseline to 68.4% (13 of 19) (95% CI,
43.4%-87.4%) in 6 months and to 100% (18 of 18) (95% CI, 81.5%-100%) in 24 months. Control clinics
had no significant increase in screening rates (baseline, 7 of 64 children [10.9%]; 6-24 months after the
intervention, 11 of 72 children [15.3%]; P = .46). Screening results were positive for 265 of 980 children
(27.0%) screened by CHICA during the study period. Among the 265 patients with positive screening
results, physicians indicated any response in CHICA in 151 (57.0%). Two children in the intervention
group received a new diagnosis of ASD within the time frame of the study.
Conclusions and Relevance
The findings suggest that computer automation, when integrated with clinical workflow and the electronic
health record, increases screening of children for ASD, but follow-up by physicians is still flawed.
Automation of the subsequent workup is still needed.
Trial Registration
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Introduction
Autism spectrum disorder (ASD) represents a range of disabilities in speech, social interaction, and
intellect, featuring repetitive stereotyped movements or behaviors, ranging from mild to severe.  The
prevalence of ASD in the United States has increased during recent decades.  The Centers for Disease
Control and Prevention estimates the prevalence of ASDs today to be 1 in 59 individuals.
Therapies for ASD, notably applied behavioral analysis, have been shown to be effective.
Controlled studies have demonstrated that applied behavioral analysis can result in significant increases in
IQ,  even into the normal range,  with improved likelihood of mainstreaming in school.  One study
suggested that therapy with applied behavioral analysis could save more than $200 000 per child.
However, the effectiveness of applied behavioral analysis depends on early initiation. There is an
association between how early children begin therapy and the benefit they experienced.  The
likelihood that a child will benefit from applied behavioral analysis decreases with age; however, many
children with ASD receive the diagnosis at an older age. Autism spectrum disorder can be diagnosed as
early as age 16 months,  yet the mean age at diagnosis in the United States is 4.5 years.
For these reasons, the American Academy of Pediatrics (AAP) has recommended that primary care
physicians caring for toddlers routinely screen for ASD at the 18-month visit and 24-month visit.  Several
screening instruments are available, but the most widely used is the 23-item Modified Checklist for Autism
in Toddlers with Follow-up (M-CHAT-F), since revised to the 20-item M-CHAT-R/F. This instrument has a
positive predictive value of 50% and can be administered in less than 10 minutes.  Moreover, the
M-CHAT-F is free and easy to download from the internet.  Despite this, fewer than half of primary care
physicians routinely screen toddlers for ASD.
Over the last 14 years, we have developed and expanded a computer-based clinical decision support system
called Child Health Improvement Through Computer Automation (CHICA), which has been shown to
improve guideline-based care for a range of clinical topics.  The purpose of this study
was to evaluate the use of CHICA to improve ASD screening and follow-up in a randomized clinical trial
among a group of community health centers.
Methods
This cluster randomized clinical trial was performed between November 16, 2010, and November 21, 2012,
among 4 pediatric primary care clinics that use CHICA. Four clinics were chosen from the 5 that use
CHICA, and they were matched in pairs based on size and racial/ethnic distribution among patients. Within
the pairs, the clinics were randomized to use CHICA with built-in ASD decision support or to continue
using CHICA without ASD decision support. Randomization by cluster precludes exact matching of
patients but avoids contamination within clinics. Randomizing by patient results in the system providing
different advice for similar patients; physicians can become confused and irritated at this outcome.
Moreover, physicians may use materials intended for intervention patients on their control patients. Thus,
despite the liabilities of randomizing by clinic, we chose this approach.
Because cluster trials randomize interventions to groups of patients (eg, medical practices) rather than to
individuals, 2 units of measurement, cluster and patient, are used. Each is reported. This study followed the
Consolidated Standards of Reporting Trials (CONSORT) extension for cluster trials  reporting guidance (
Figure 1). This study was approved by the Indiana University Institutional Review Board, and parental
consent was waived because of minimal risk and because consenting all children seen in the clinics without
affecting study outcomes was impracticable. The trial protocol is available in Supplement 1.
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Intervention
The AAP policy statement regarding the identification and evaluation of children with ASD includes an
algorithm describing when children should be screened and referred for a full evaluation.  This algorithm
was built into CHICA as an ASD module. CHICA is a rule-based system that has operated in primary care
pediatric clinics at the Eskenazi Health System in Indianapolis, Indiana, since 2004.
CHICA has been described in detail elsewhere ; in brief, the system communicates with the underlying
electronic health record (EHR) so that when a patient registers for care, CHICA analyzes the child’s EHR
(demographic characteristics, morphometric characteristics, diagnoses, and medications) and selects the
highest-priority 20 yes or no questions covering a wide range of primary care issues to ask the family.
These are displayed on a sheet of scannable paper or an electronic tablet  that is given to the family to
complete in the waiting room. The questions are produced in English and Spanish. Our data show that
approximately 90% of these forms are completed. CHICA analyzes the responses to these questions and
selects the 6 most important alerts or reminders for the clinician. These are assembled into a visit agenda
that can be printed on a scannable worksheet or displayed from within the clinician’s EHR. The clinician
can respond to the alerts and reminders in the agenda by checking associated boxes in the EHR. These
responses also store data that can be used for future decision support. Last, CHICA has a library of patient
and physician handouts it can print as needed based on issues it has identified. CHICA covers a wide range
of topics in primary pediatric care, from lead screening  and asthma  to adolescent depression  and type
2 diabetes.
The AAP ASD guidance was encoded in the CHICA ASD module by creating rules that directed both
surveillance and screening.  To conduct surveillance (as defined in the AAP guideline ), CHICA’s
prescreening form asked parents whether they were concerned about the child’s development or whether
the child had a sibling with ASD. If both of these were true or if 1 was true and the clinician had expressed
developmental concerns in CHICA at an earlier visit, then CHICA produced an alert to the clinician that
the child should be referred immediately for an ASD evaluation.
Otherwise, CHICA produced an M-CHAT-F ASD screening form.  (In subsequent versions, CHICA was
programmed to produce the M-CHAT-R/F screening form.) This form was originally printed on a barcoded
sheet of paper that was completed in the examination room, scanned, and automatically scored by CHICA.
In the newer version of CHICA, in which families completed the questionnaire on an electronic tablet, the
M-CHAT-F (or M-CHAT-R/F) was displayed on the tablet and completed in the waiting room.
Through the EHR, CHICA alerted the clinician if the M-CHAT-F had a positive result. Moreover, CHICA
printed the standard follow-up interview questions that were relevant to the items failed on the M-CHAT-F
for the clinician to ask. The alert also asked the clinician to indicate in the EHR whether his or her
assessment was concern for ASD and whether a referral to a diagnostic clinic was made. Because CHICA
does not capture whether follow-up questions were used, we refer only to the M-CHAT.
At subsequent visits, CHICA prompted clinicians to indicate whether a diagnostic evaluation had been
completed and what its result was. If a clinician indicated that the child was given a diagnosis of ASD, then
CHICA implemented a series of monitoring questions for parents regarding financial concerns, behavioral
concerns, need for respite care, and complementary and alternative therapies. If the parent indicated needs
in these areas, then the clinician received an alert, and CHICA generated a handout to help the clinician and
family navigate the issue.
Physicians and staff in the intervention group were told that CHICA would produce an M-CHAT screening
form and that the form would be scored and the results provided to the physician through CHICA,
including the relevant follow-up questions. No other training on ASD screening was provided except
through the prompts in CHICA. No training was provided to the control group.
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Review of CHICA Data
Medical Record Abstraction
Setting
This study took place in 4 primary care pediatric clinics in the Eskenazi Health System in Indianapolis,
Indiana. The experimental intervention in 2 of these clinics included the enhanced version of the CHICA
with the CHICA ASD module. The 2 control clinics also had CHICA, but it did not include the ASD
module. Clinicians in control clinics identified and cared for children with ASD using their standard
methods. Participants were automatically enrolled in the study based on which clinics they attended.
Intervention clinic staff and physicians were instructed in the use of the CHICA ASD module during a
1-hour meeting. All 4 clinics had user support, consisting of a help desk and quarterly meetings with clinic
teams to discuss general CHICA issues.
Data Sources and Collection
To measure the effect of CHICA on ASD screening and surveillance, we assessed the percentage of
children at the 18-month or 24-month visits who were screened using an ASD-specific screening tool
between November 16, 2010, and November 21, 2012. Data were collected from 2 sources: a review of
CHICA data and medical record abstraction.
As parents and physicians entered data directly into CHICA, information about the
screening and diagnosis of ASD was collected automatically in the intervention clinics throughout the
study period.
Because physicians may have conducted screening without recording it in
CHICA and because ASD screening data were not collected by CHICA in the control group, we used
manual medical record abstraction to assess each clinic’s surveillance and screening rates related to ASD,
independent of what was recorded in CHICA. Trained research assistants reviewed both the electronic
medical record and paper records for a variety of information, including ASD screening and surveillance
according to the AAP guideline.  A random sample of medical records of eligible patients was abstracted
at baseline and at 6, 12, 18 and 24 months after starting the intervention in both the intervention and control
clinics. Research assistants were not blinded to group allocation. To assess the reliability of medical record
abstraction, a 20% sample of the medical records was abstracted twice. Agreement on the primary outcome
of ASD screening rates was substantial, with a κ of 0.79.
Participants
Children 3 years or younger who were seen in 1 of the 4 study clinics within 1 month of their 18-month or
24-month birthday were eligible for inclusion. Children born before 35 weeks’ gestational age and/or with
a diagnosis of Down syndrome (trisomy 21) were excluded. The EHR was used to select eligible patients
who had a visit to 1 of the clinics before the intervention started and to select samples at 6-, 12-, 18-, and
24-month intervals (±2 weeks) after the initiation of the intervention. Those who had a visit to the clinic
when either 17 to 23 months of age or 24 to 36 months of age were eligible. A patient could have his or her
medical record reviewed at only 1 time point. A random sample of eligible patients was identified.
Outcome Measures
The primary outcome of interest was the percentage of children at the 18- or 24-month visits who were
screened using an ASD-specific screening tool (ie, the M-CHAT). Data were also gathered to examine the
following secondary outcome measures: (1) number of screened children who had a positive ASD
screening result at the 18- or 24-month visit, (2) number of children with a positive screening who were
referred for evaluation after the positive ASD screening result, (3) number of children who received a
diagnosis of ASD after completion of a comprehensive ASD evaluation, and (4) percentage of children
referred for audiologic evaluation after a positive ASD screening result.
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Power Calculations
We based our target sample size on the assumption that there would be a 10% screening rate at baseline and
an increase to 40% in the intervention clinics. This gave us 90% power to detect at least this difference,
setting α at .05, with a sample size of 49 per group at baseline and at follow-up. Because the unit of
randomization was the clinic and the patients are nested within the clinic, we accounted for intracluster
correlation by assuming screening rates varied from 6% to 12% by clinic. This translated to an intraclass
correlation coefficient of 0.0041. To be conservative, we used an intraclass correlation of 0.0082, resulting
in a sample size of 62 per group per time point.
Statistical Analysis
Statistical analysis was performed between February 6, 2017, and June 1, 2018. The primary outcome,
percentage of eligible children screened for ASD, was evaluated first with a run chart showing the
percentage of the sample screened at each time point (baseline and 6, 12, 18, and 24 months after initiation
of the CHICA ASD module), with separate lines for each group. Screening rates at each time point were
compared by means of the Fisher exact test. All P values were from 2-sided tests and results were deemed
statistically significant at P < .05. To control for intraclass (within-clinic) correlations, we compared the
proportion of children screened between the intervention and control groups by modeling the
postintervention outcome (screened: yes or no) using a logistic model with a term for group and an
exchangeable correlation structure that adjusted for the correlation of children from the same clinic.
Because of imbalanced race/ethnicity in the intervention and control groups, this analysis also controlled
for race/ethnicity. The postintervention data at different time points were combined for modeling.
Secondary outcomes were descriptive and are presented in the text as proportions with 95% CIs.
Analyses were performed with SAS/STAT software, version 9.4 (SAS Institute Inc). Graphs were produced
using R Core Team, version 2015 (R Project for Statistical Computing).
Results
At the request of clinic leadership, the 18-month M-CHAT was stopped within 6 months of starting the
intervention. Physicians believed it was overwhelming for families to complete the M-CHAT at the 18-
month visit in addition to the Ages and Stages Questionnaire developmental screening, which the clinics
were also using according to AAP recommendations. CHICA continued to screen for ASD with the 24-
month M-CHAT.
M-CHAT Test Positivity
By the end of the study, 40 820 children 21 months or younger had visits using the CHICA system in the 4
study clinics, 34.0% (n = 13 871) in intervention clinics and 66.0% (n = 26 946) in control clinics. During
the intervention, M-CHAT screening tests were printed for 1653 children, aged between 20 and 36 months.
Of the 1653 M-CHAT tests printed, 980 (59.3%) were completed and scanned back into the system for
scoring by CHICA. We suspect that some physicians also scored M-CHAT tests manually. Scored
M-CHAT tests showed that 265 children had results possibly indicative of ASD, for a 27.0% positive
screening rate.
Effects of CHICA on ASD Screening
Abstractions were completed on 274 medical records: 129 at baseline, 38 at the 6-month time point, 36 at
the 12-month time point, 35 at the 18-month time point, and 36 at the 24-month time point after initiating
the intervention. By design, these were evenly divided among intervention clinics (n = 138) and control
clinics (n = 136).
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The sex, race/ethnicity, and insurance status of the children included in the medical record abstraction are
shown in the Table. All children were between 23 and 30 months of age by design. There were more boys
(n = 162) than girls (n = 101). Most children (242 of 263 [92.0%]) were covered by Medicaid. Most
children (244 of 263 [92.8%]) were nonwhite. Overall, 138 (52.5%) were African American; 96 (36.5%)
were Hispanic. There was a larger Hispanic population in the control group than in the intervention group
(91 of 136 [66.9%] vs 5 of 127 [3.9%]; P < .001) and a larger African American population in the
intervention group than in the control group (106 of 127 [83.5%] vs 32 of 136 [23.5%]) (P < .001).
The primary outcome of the study was the rate at which eligible patients were screened for ASD using a
standardized screening instrument such as the M-CHAT. This rate increased over time in the intervention
group but not the control group. At baseline, none of the children in the intervention group were screened.
In the control group, 7 of 64 children (10.9%) were screened. During the intervention period, 57 of 73
children (78.1%) in the intervention group were screened. The intervention clinics’ screening rates
increased from 0% (95% CI, 0%-5.5%) at baseline to 68.4% (13 of 19) (95% CI, 43.4%-87.4%) at 6
months to 100% (18 of 18) (95% CI, 81.5%-100%) at 24 months. The control group screening rate during
the study period was only 15.3% (11 of 72 children) at 6 to 24 months after the intervention, peaking at 4 of
18 children (22.2%) at 24 months. Differences between groups became statistically significant during the
intervention period (Figure 2). Comparisons controlling for intraclass correlation showed that intervention
clinics were much more likely to screen children for ASD (odds ratio, 108.23 [95% CI, 22.65-517.2]).
Despite the increased ASD screening, clinics and physicians were not as effective in following up when
patients had positive screening results. Among the 265 patients with a positive M-CHAT result, physicians
indicated any response to the positive M-CHAT result for only 151 children (57.0%; 95% CI, 51.0%-
62.9%). In 103 of the 151 with responses (68.2%; 95% CI, 60.8%-75.6 %), pediatricians indicated the child
did not have ASD, 52 of 151 children (34.4%; 95% CI, 26.8%-42.0%) were referred for ASD evaluation,
17 of 151 children (11.3%; 95% CI, 6.2%-16.3%) were suspected of having ASD but not referred, and 5 of
151 children (3.3%; 95% CI, 0.4%-6.2%) were referred for audiologic evaluation (Figure 3).
Medical record abstraction showed that, although children in intervention clinics were more likely to be
screened for ASD, physicians in those clinics were less likely to document screening results when they
were positive (odds ratio, 0.18 [95% CI, 0.02-1.89]). Nonetheless, full referral and evaluation for ASD
were more likely to occur in the intervention group (odds ratio, 19.88 [95% CI, 3.33-118.65]).
By the end of the study period, 52 children had documentation in CHICA of referral for an ASD
evaluation. Two of 138 children (1.4%) in the intervention group had a new ASD diagnosis recorded during
the intervention by medical record review. Among all children screened by CHICA, 15 of 980 (1.5%)
received an ASD diagnosis. Because 15 children were identified as having ASD among the 151 children
with positive screening results who were evaluated, the positive predictive value of the M-CHAT could be
estimated at 10%.
Discussion
Automated screening and clinical decision support had an effect on the rate of routine screening for ASD in
general pediatric practice. Screening in the intervention clinics went from 0% to 68.4% within 6 months
and then to 100% during the 24 months of the study. This outcome, while larger, is consistent with previous
work on clinical decision support systems.  It is not clear why the rate increased over time, but
previous work with CHICA shows that physicians seem to become accustomed to decision support over
time.  Automated systems that screen for ASD have been described that also score the follow-up
interview in real time and could improve physician response rates.  However, this study is the first, to our
knowledge, to rigorously test the effectiveness of such systems for improving rates of screening consistent
with authoritative guidelines.
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The control clinics had access to the M-CHAT-F tool but to no other systematic approach to increase
screening. Therefore, the CHICA module was not compared with a competing improvement strategy.
Daniels et al  conducted an extensive review of approaches to improving early detection of ASD. Among
the 40 studies reviewed, a small amount were conducted in primary care, included ASD screening, and
assessed rates of screening. Only 1 study was a randomized clinical trial, and it achieved a screening rate of
81%. Most studies assessed only postintervention screening rates, which varied between 80% and 90%.
One study, which assessed screening rates before and after “academic detailing,” achieved a 71% screening
rate.
Our results show that automating surveillance for ASD and automating administration of a screening test
can result in very high rates of screening. This method also has the advantage of ensuring that scoring is
done correctly. The weak point in the process appears to be the clinical response to screening results, as
evidenced by the apparent nonresponse of physicians to almost half of positive M-CHAT results.  This
finding is consistent with previous work on clinical decision support systems.  In fact, the greater than
50% response rate achieved by CHICA is high compared with other types of physician alerts, which may
be ignored more than 90% of the time.  We believe that embedding the decision support within a visit
agenda significantly improved this response rate. Therefore, even with this weak point, screening and
subsequent evaluation for ASD were improved with CHICA’s ASD module.
Two new diagnoses of ASD (1.4%) were documented in the medical records reviewed. Physicians reported
15 ASD diagnoses (1.5%) among all children exposed to the CHICA module. These percentages are
slightly lower than the estimated prevalence of ASD, but limited time and local diagnostic capacity may
explain this finding. The study was not powered, nor was it of sufficient duration, to detect a difference in
rates of diagnosis of ASD. We may anticipate that ASD detection will improve, but the 57.0% response rate
from physicians, combined with the poor follow-through by parents,  will attenuate the effect of universal
screening.
Limitations
This study has limitations that warrant consideration. The study did not show adherence to the AAP
guidelines to screen children at 18 months and did not show that ASD screening and developmental
screening can be conducted at the same visit per AAP recommendations. The study was confined to a small
number of clinics. Its randomized design, however, was powered to detect an intervention effect much
smaller than we found. The randomization failed in that the racial/ethnic makeup of the intervention and
control clinics differed. However, these differences were controlled for in the analyses, and the inclusion of
baseline and postintervention data shows that this difference is unlikely to explain the results.
The population of patients in the intervention clinics was 83.5% African American. Racial minority groups,
especially African American individuals, are less likely to be screened for and receive a diagnosis of
ASD.  It is notable, therefore, that screening and follow-up rates were increased in this group.
Unfortunately, the clinics thought it was not feasible to conduct both the M-CHAT and the Ages and Stages
Questionnaire at the same visit. Resolving this issue may require changes in the clinic workflow or for
families to complete these procedures at home (eg, through an online patient portal).
Another challenge to screening with the M-CHAT-F and M-CHAT-R/F is the high rate of positive screening
results (27.0% in our study). This finding is comparable to positive screening result rates in similar
populations described by Daniels et al.  The follow-up questions in the M-CHAT-F are intended to reduce
the false-positive rate. CHICA automatically produced follow-up questions, but we do not know how well
they were used. The high false-positive rate means that most children with positive screening results will
not have ASD, and it has been suggested, therefore, that referral is unjustified.  In fact, since 15 children
were identified as having ASD among the 151 children with positive screening results who were evaluated,
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the positive predictive value of the M-CHAT could be estimated at 10%. This finding, too, may explain
why many physicians did not respond to positive screening results.
Therefore, screening for ASD is but the first step in improving outcomes for children. Too often, there are
insufficient resources available to make proper diagnoses of ASD and even fewer resources available to
treat children with a diagnosis of ASD. Improving those factors will be necessary to improve the outlook of
the many children in the United States who have ASD.
Conclusions
Automation, as with the CHICA system, which integrates into routine care and ensures that screening is
administered to most eligible patients, can drastically improve the rates at which children are screened for
ASD. This automated screening is necessary, but not sufficient, to improve the care of children. More work
is needed to automate the further evaluation of children who screened positive for ASD.
Notes
Supplement 1.
Trial Protocol
Supplement 2.
Data Sharing Statement
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Figure 1.
CONSORT Diagram for Cluster Randomized Trial Showing Randomization Allocation, Follow-up, and Analysis
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Table.
Sex, Race/Ethnicity, and Insurance Coverage of Children
Characteristic Children, No./Total No. (%)
Overall (N = 274) Intervention (n = 138) Control (n = 136)
Sex
Female 101/263 (38.4) 43/127 (33.9) 58/136 (42.6)
Male 162/263 (61.6) 84/127 (66.1) 78/136 (57.4)
Race/ethnicity
Asian 4/263 (1.5) 2/127 (1.6) 2/136 (1.5)
Native American 2/263 (0.8) 2/127 (1.6) 0
Black 138/263 (52.5) 106/127 (83.5) 32/136 (23.5)
Hispanic 96/263 (36.5) 5/127 (3.9) 91/136 (66.9)
Unknown 4/263 (1.5) 1/127 (0.8) 3/136 (2.2)
White 19/263 (7.2) 11/127 (8.7) 8/136 (5.9)
Insurance
Commercial 10/263 (3.8) 4/127 (3.1) 6/136 (4.4)
Medicaid 242/263 (92.0) 119/127 (93.7) 123/136 (90.4)
Self-pay 9/263 (3.4) 3/127 (2.4) 6/136 (4.4)
Special payer 1/263 (0.4) 1/127 (0.8) 0
Unknown 1/263 (0.4) 0 1/136 (0.7)
Missing values are excluded.
a
a
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Figure 2.
Run Chart Showing the Rates of Autism Spectrum Disorder Screening in Eligible Children During the Study
Period
The screening rate at each time point for each group was estimated using the binomial distribution, and the 95% CIs (error
bars) were from Clopper-Pearson (exact)–type intervals.
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Figure 3.
Physician Responses to Alerts Indicating Child Had a Concerning Modified Checklist for Autism in Toddlers
Result
Total percentages exceed 100% because physicians could check more than 1 response per child. ASD indicates autism
spectrum disorder; and CHICA, Child Health Improvement Through Computer Automation system.
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